Ree AH, Meltzer S, Flatmark K, Dueland S (2026)
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial
Br J Radiol (in press)
DOI 10.1093/bjr/tqag133, PubMed 42233285

Meltzer S, Landmark SS, Šaltytė Benth J, Negård A, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Flatmark K, Ree AH (2026)
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data
Immunotargets Ther, 15, 594176
DOI 10.2147/ITT.S594176, PubMed 42158080

Torgunrud A, Davidson B, Nilsen TA, Nitschke Marcussen IK, Dagenborg VJ, Lund-Andersen C, Flatmark K (2026)
Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei
Eur J Surg Oncol, 52 (7), 111873 (in press)
DOI 10.1016/j.ejso.2026.111873, PubMed 42119195